Table 5. Baseline and clinical characteristics of patients according to their vital status at the end of the study.
| Parameter | Whole Group | Died | Survived | P |
|---|---|---|---|---|
| Subjects, n | 408 | 75 | 333 | – |
| Age, y | 67.4 (9.0) | 73.1 (8.2) | 66.2 (8.5) | <0.001 |
| Sex, M/F, No. | 348/60 | 64/11 | 284/49 | 0.992 |
| Onset of symptoms, y | 12.4 (11.6) | 14.2 (12.1) | 11.7 (10.9) | 0.028 |
| Pack-years smoked | 29.6 (27.2) | 35 (29.1) | 29.1 (26.6) | 0.123 |
| Body mass index, kg/m2 | 21.5(3.8) | 21.0(3.6) | 21.6(3.8) | 0.216 |
| Hb, g/L | 135.6 (17.4) | 133.2 (23.7) | 136.4 (15.3) | 0.018 |
| CRP, IU/mL | 17.4 (28.8) | 23.6 (43.9) | 16.0 (24.2) | 0.017 |
| Albumin, mg/dL | 38.2 (4.4) | 37.0 (4.2) | 38.3 (4.4) | 0.002 |
| Blood glucose, mmol/L | 5.8 (1.9) | 6.0 (2.6) | 5.7 (1.7) | 0.772 |
| Length of hospitalization, d | 11 (5.9) | 12.5 (4.9) | 10.5 (4.7) | 0.005 |
| Isolation of PPM, No. | 184 (54.6%) | 45 (75%) | 139 (50.2%) | <0.001 |
| Bronchiectasis | 150 (36.8%) | 39 (52%) | 111 (33.3%) | 0.002 |
Data are presented as n (%) or mean ±SD unless otherwise stated.